| Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, P Rossing, P Kolkhof, ... New England journal of medicine 383 (23), 2219-2229, 2020 | 2851 | 2020 |
| Cardiovascular events with finerenone in kidney disease and type 2 diabetes B Pitt, G Filippatos, R Agarwal, SD Anker, GL Bakris, P Rossing, A Joseph, ... New England Journal of Medicine 385 (24), 2252-2263, 2021 | 1716 | 2021 |
| Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes R Abdi, P Fiorina, CN Adra, M Atkinson, MH Sayegh Diabetes 57 (7), 1759-1767, 2008 | 710 | 2008 |
| Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes P Fiorina, M Jurewicz, A Augello, A Vergani, S Dada, S La Rosa, M Selig, ... The journal of Immunology 183 (2), 993-1004, 2009 | 500 | 2009 |
| Abatacept in B7-1–positive proteinuric kidney disease CC Yu, A Fornoni, A Weins, S Hakroush, D Maiguel, J Sageshima, ... New England Journal of Medicine 369 (25), 2416-2423, 2013 | 470 | 2013 |
| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 461 | 2021 |
| A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes MA Niewczas, ME Pavkov, J Skupien, A Smiles, ZI Md Dom, JM Wilson, ... Nature medicine 25 (5), 805-813, 2019 | 445 | 2019 |
| Kidney transplantation in children VR Dharnidharka, P Fiorina, WE Harmon New England Journal of Medicine 371 (6), 549-558, 2014 | 329 | 2014 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological research 182, 106320, 2022 | 324 | 2022 |
| Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control … SB Solerte, F D’Addio, R Trevisan, E Lovati, A Rossi, I Pastore, ... Diabetes care 43 (12), 2999-3006, 2020 | 300 | 2020 |
| The clinical impact of islet transplantation P Fiorina, AMJ Shapiro, C Ricordi, A Secchi American Journal of Transplantation 8 (10), 1990-1997, 2008 | 280 | 2008 |
| Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 SB Solerte, A Di Sabatino, M Galli, P Fiorina Acta diabetologica 57 (7), 779-783, 2020 | 224 | 2020 |
| Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants P Fiorina, F Folli, G Zerbini, P Maffi, C Gremizzi, V Di Carlo, C Socci, ... Journal of the American Society of Nephrology 14 (8), 2150-2158, 2003 | 219 | 2003 |
| Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients P Fiorina, F Folli, F Bertuzzi, P Maffi, G Finzi, M Venturini, C Socci, ... Diabetes Care 26 (4), 1129-1136, 2003 | 217 | 2003 |
| ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration S Zandi, S Nakao, KH Chun, P Fiorina, D Sun, R Arita, M Zhao, E Kim, ... Cell reports 10 (7), 1173-1186, 2015 | 209 | 2015 |
| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 205 | 2021 |
| Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis F D’Addio, A Valderrama Vasquez, M Ben Nasr, E Franek, D Zhu, L Li, ... Diabetes 63 (9), 3041-3046, 2014 | 184 | 2014 |
| Cardiovascular outcomes after kidney–pancreas and kidney–alone transplantation E La Rocca, P Fiorina, V Di Carlo, E Astorri, C Rossetti, G Lucignani, ... Kidney international 60 (5), 1964-1971, 2001 | 182 | 2001 |
| Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes M Jurewicz, S Yang, A Augello, JG Godwin, RF Moore, J Azzi, P Fiorina, ... Diabetes 59 (12), 3139-3147, 2010 | 180 | 2010 |
| Targeting CD22 reprograms B-cells and reverses autoimmune diabetes P Fiorina, A Vergani, S Dada, M Jurewicz, M Wong, K Law, E Wu, Z Tian, ... Diabetes 57 (11), 3013-3024, 2008 | 172 | 2008 |
Francesca D'AddioInternational Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica InvernizziVerified email at unimi.it
